Cannabis Consumer Price Index: Executive Summary – August 2019 (Released October 2019)
October 9th, 2019
App, Policy, Top News
The one-of-a-kind Cannabis Market CPI is a benchmark of retail sales pricing across cannabis products in select legalized U.S. markets. The index currently reports sales in Arizona, California, Colorado, Nevada, and Oregon, states that generated more than 60 percent of legalized U.S. sales in 2018. Underlying pricing data is the compilation of actual dispensary transactions captured by BDS Analytics’ GreenEdge™ Retail Sales Tracking Platform.
The baseline of measurement represents the launch of adult-use sales in California in January of 2018. In order to standardize retail pricing data for Flower and Concentrates, all transactions are normalized to price per gram.
For Ingestible, Topicals and Vapes, sales are converted to a price per unit measure. BDS Analytics’ CPI is unique in its ability to index retail pricing across all product categories, a significant insight considering the rapid market growth largely driven by branded products in all categories.
BDS Analytics’ CPI for August 2019 stands at 104.01, representing less than two-tenths of a percent decrease from the trailing month. Compared to August 2018, the CPI average retail prices have declined nearly three percent. Year-to-date average retail prices have declined less than one percent.
The index score is positive for Pre-Rolled joints, Ingestible and Topicals, indicating an increase of the average retail price of these product categories relative to January 2018. Other product categories, such as Flower, Vape, and Dabbable Concentrates (referenced in table as ‘Concentrates – No Vape’), have negative CPI scores. The average retail prices of Flower, Dabbable Concentrates, and Vape all increased by one point, when compared to the trailing month.
GreenEdge® Insights: In August 2019, legal cannabis sales at dispensaries across Arizona, California, Colorado, Oregon, and Nevada reached a combined $639.2 million, a four percent increase from the trailing month and a 21 percent increase from the prior August. After years of declining flower prices, a temporary floor appears to have been reached in the fourth-quarter of 2018. Thus far in 2019 we have seen a rebound as flower prices have steadily increased over the past few months. The phenomenon of higher flower prices isn’t geographically isolated as the trend is evident in multiple markets.
With significant flower production having been allocated for to extraction to feed Concentrates, Vape and other product categories, the supply of flower for smoking has diminished over time.
Recent negative news for the vape category could have a chilling effect and could further boost demand for flower in the near term. With limited supply, should demand for flower continue to strengthen we can anticipate further increases in flower pricing.
Stay tuned for the next installment of the CPI for a recap of Cannabis sales trends with September data.
For further details about these insights and more, please contact [email protected]
About BDS Analytics:
Headquartered in Boulder, Colorado, BDS Analytics provides businesses with comprehensive, actionable, and accurate cannabinoid market intelligence and consumer research. The company provides a holistic understanding of the cannabinoid market by producing insights from tracking and categorizing millions of individual consumer transactions, extensive and detailed consumer research and generating market-wide cannabinoid industry financial projections, all delivered through its market-leading GreenEdge® platform. To learn more about how you can utilize BDS Analytics’ industry-leading market research, please visit www.bdsanalytics.com.
BDS Analytics’ have an exclusive media partnership with CFN Media, the leading financial network in Cannabis.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Media Group (CannabisFN), owned and operated by CFN Enterprises Inc. (OTCQB: CNFN), is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.